Our Mastery
Testimonial
- "Amazing success ratio in such uncertain market and paid service is very affordable ...Good job done by your team...keep it up guys."
-Venkat (Chennai)
Party Plot Owner - "I am trading in stock market since last 8 years; I have subscribed services from many advisory companies. Conclusion is that no one can provide 100% accuracy in this NSE market. But accuracy of intraday tips from this firm is the highest among all share tips companies" Rahul Varma (Mumbai)
Owner of an Insurance Firm - "I have taken free trial of intraday tips for 2 days and 80% call is profitable. Then I have subscribed paid membership for trading advice and now I am quite satisfied with services. Important thing is do not think more; Just trade what you are suggested" -Kevin Patel (Ahmedabad)
BDM at IT Company - "Made Good Profit in the Intraday, Jackpot Calls, F&o Tips. Overall Service is very good. Especially I like your Fast tips Sms Service & Exit Call System. Your tips have very good performance." -Manoj Arora (Delhi)
CEO of Real Estate Company
Celestial Biolabs Ltd share price today (on 22 March 2023).
We Provide Best stock tips for Celestial Biolabs Ltd. A1 Intraday Tips is accurate share tips Provider Company in India in Nse market. A1 Intraday Tips, also provide Daily Charts with Nse Share Market current price of Celestial Biolabs Ltd with today performance in nse market. Contact Us for Jackpot Stock tips.
Get Free Stock Tips for Celestial Biolabs Ltd
BSE: 532871 | NSE: CELESTIAL | ISIN: INE221I01017 Market Cap: [Rs.Cr.] 24 | Face Value: [Rs.] 10 Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Celestial Biolabs Ltd (CBL) is an ISO 9001-2000 certified company with a decade of experience in Insilico Drug Discovery and Development, and contract research services.Celestial Biolabs is recognized by DSIR (Government of India) for its R&D endeavors in the Insilco Drug Discovery software development.Celestial has been providing customized solutions and services in Bio-IT as well as research services over a decade.
CELESTIAL LABS LIMITED was incorporated as a Private Limited Company on November 19, 1997 as 'Celestial Technologies Private Limited'. Mr. Rajani Kanth Katragadda and Mr. Vijay Marur have promoted the company. The company was later converted into a Public Limited Company under the name 'Celestial Technologies Limited' on December 6, 1999 and has been subsequently renamed as 'CELESTIAL LABS LIMITED' effective from February 13, 2004. The present promoter of the company is Mr. Aditya Narayan Singh. The Original promoters sold their holding to the present promoter on 7.11.1998. The company has received ISO 9001-2000 certificate. The company has been providing customized enterprise solutions, bioinformatics services and also involved in development of biopharmaceuticals and industrial enzymes.
The company is in contact with Centre for Cellular & Molecular Biology (CCMB) under the aegis of Council for Scientific and Industrial Research, Ministry of Science and Technology, Government of India and Indian Institute of Chemical Technology (IICT), premier chemical and Biological Institutions in Hyderabad to work on collaborative research projects to be funded by Department of Science and Technology New Delhi. The Company has offer both service and solutions like application management for legacy system, upgrade and maintenance system. Molecular informatics, data management, algorithm development, compliances and data curation, warehousing and visualization and custom built application are the current part of services. To strengthen the Drug molecule development and related services like Target identification and advance fragment based lead optimization solution, Celestial has developed a de novo drug design tool 'CELSUITE' to aid the pharma industry in finding the lead molecules for drug discovery and protected the IPR by filing under the Copyright Act, 1957.
(Appraised and funded by Department of Science and Technology, New Delhi). The company is setting up an Industrial biotechnology facility to manufacture industrial enzymes. This facility would also include the Development laboratories for carrying out further R & D activities to develop new related products for reducing Wrinkles / Stretch marks and acceleration of wound healing from the same chemical structure of vitiligo. The proposed Facility is being set up at Shapoorji Pallonji Biotech Park in Genome Valley at Hyderabad in Andhra Pradesh.
According to the Individual - Audited financial statement for the Year of 2012, total net operating revenues decreased with -19.12%, from INR 25.32 tens of millions to INR 20.48 tens of millions. Operating result decreased from INR 6.06 tens of millions to INR 4.26 tens of millions which means -29.70% change. The results of the period decreased -61.98% reaching INR 0.92 tens of millions at the end of the period against INR 2.42 tens of millions last year. Return on equity (Net income/Total equity) went from 0.82% to 0.31%, the Return On Asset (Net income / Total Asset) went from 3.16% to 1.27% and the Net Profit Margin (Net Income/Net Sales) went from 9.56% to 4.49% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 4.49% compared to 4.17% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 8.07 to 24.80 when compared to the previous year.
( Equity cash, Nse fno, jackpot call, sure shot call, btst/stbt call )
Under one plan with lowest price
for free trial visit Stock tips for day Traders
Nse Listed Companies with Live Charts
with live charts starting with that Alphabet.)
| A | B | C | D | E | F | G | H | I | J |
| K | L | M | N | O | P | Q | R | S | T |
| U | V | W | X | Y | Z |
